When.com Web Search

  1. Ad

    related to: psoriasis injection treatment skyrim release date

Search results

  1. Results From The WOW.Com Content Network
  2. Risankizumab - Wikipedia

    en.wikipedia.org/wiki/Risankizumab

    Risankizumab was approved by the U.S. Food and Drug Administration (FDA) for treatment of moderate-to-severe plaque psoriasis in April 2019. [13] [10] [14]The FDA approved risankizumab based on evidence primarily from five clinical trials (Trial 1/NCT02684370, Trial 2/NCT02684357, Trial 3/NCT02672852, Trial 4/ NCT02694523, and Trial 5/NCT02054481) of 1606 participants with moderate to severe ...

  3. Tildrakizumab - Wikipedia

    en.wikipedia.org/wiki/Tildrakizumab

    In March 2018, it was approved by the Food and Drug Administration for the treatment of moderate-to-severe plaque psoriasis as an injection for subcutaneous use in the United States. [ 5 ] In September 2018, it was approved by the European Commission for the treatment of adults with moderate-to-severe chronic plaque psoriasis who are candidates ...

  4. List of The Elder Scrolls video games - Wikipedia

    en.wikipedia.org/wiki/List_of_The_Elder_Scrolls...

    The Elder Scrolls games take place in the fictional world of Nirn, on the continent of Tamriel. The first game, The Elder Scrolls: Arena , was released in 1994. It was intended for players to assume the role of an arena combatant, but development shifted the game into a role-playing game (RPG), beginning a tradition that persists throughout the ...

  5. Ustekinumab - Wikipedia

    en.wikipedia.org/wiki/Ustekinumab

    Ustekinumab is used to treat psoriasis. [29] This includes psoriatic arthritis when it affects the skin. [31] [29] It is indicated for the treatment of adult and adolescent patients (12 years and older) with moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapy, and adults with active psoriatic arthritis (PsA) alone or in combination with methotrexate.

  6. List of Bethesda Softworks video games - Wikipedia

    en.wikipedia.org/wiki/List_of_Bethesda_Softworks...

    Release date Developer(s) Ref. The Elder Scrolls III: Tribunal: The Elder Scrolls III: Morrowind: Windows November 6, 2002: Bethesda Game Studios [169] The Elder Scrolls III: Bloodmoon: Windows June 3, 2003 [170] The Elder Scrolls IV: Knights of the Nine: The Elder Scrolls IV: Oblivion: Windows November 21, 2006 [171] Xbox 360 [172] PlayStation ...

  7. Secukinumab - Wikipedia

    en.wikipedia.org/wiki/Secukinumab

    Secukinumab inhibits a member of the cytokine family, interleukin 17A, which is produced mainly by inflammatory T helper 17 cells. [11] IL17A is upregulated in serum of people with psoriasis and in the synovial fluid of people with psoriatic arthritis, and promotes inflammation when it binds to the interleukin-17 receptor which is expressed in various types of cells, including keratinocytes in ...

  8. The Elder Scrolls V: Skyrim - Wikipedia

    en.wikipedia.org/wiki/The_Elder_Scrolls_V:_Skyrim

    The Elder Scrolls V: Skyrim is a 2011 action role-playing game developed by Bethesda Game Studios and published by Bethesda Softworks.It is the fifth main installment in The Elder Scrolls series, following The Elder Scrolls IV: Oblivion (2006), and was released worldwide for Microsoft Windows, PlayStation 3, and Xbox 360 on November 11, 2011.

  9. Adalimumab - Wikipedia

    en.wikipedia.org/wiki/Adalimumab

    Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.